Skip to main content
Canna~Fangled Abstracts

COVID-19 Infection: Effects of Cannabidiol on Patients

By February 21, 2025April 2nd, 2025No Comments
PubMed is a free, comprehensive database of scientific and medical literature, primarily focusing on biomedical and life sciences research. It is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). PubMed is one of the most widely used resources for healthcare professionals, researchers, and students to access peer-reviewed articles, clinical studies, and other scientific publications.

COVID-19 Infection: Cannabidiol (CBD) shows potential in supporting patients by reducing inflammation, easing symptoms, and promoting recovery, highlighting its therapeutic benefits

Randomized Controlled Trial
. 2025 Feb;27(2):78-81.

Cannabidiol and Its Effects on Patients with COVID-19 Infection

Yuval Kuntzman 1, Gilad Halpert 2, Howard Amital 3
Affiliations 
  • PMID: 40170643

Abstract

Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease pathway is heavily influenced by different inflammatory cytokines. There is ample evidence of cannabidiol (CBD) immunomodulation effects.

Objectives: To investigate the effect of CBD on patients with SARS-CoV-2 and to measure the impact on inflammatory cytokines.

Methods: A double blind, placebo-controlled study to compare the clinical outcomes and selected serum cytokine levels in patients with SARS-CoV-2 that received sublingual CBD extraction. Seven patients were randomized to the treatment arm and three to the placebo group.

Results: Clinical outcomes were better in the patient group that received sublingual CBD vs. patients receiving placebo treatment. Serum cytokine mean concentration levels showed differences between the two groups but of mixed trends.

Conclusions: Patients presenting with SARS-CoV-2 and receiving CBD sublingually had better outcomes than those receiving a placebo, although these results did not reflect in selected serum cytokines. Further study is needed.

PubMed Disclaimer

Publication types

MeSH terms

Substances

COVID-19 Infection: Patients presenting with SARS-CoV-2 and receiving CBD sublingually had better outcomes than those receiving a placebo.Stay informed with the latest scientific insights, evidence-based independent research and discoveries on the ECS, cannabis medicine and more

Revolutionary Research on the ECS, cannabinoids and cannabis-based medicine for healthcare from a trusted nonprofit.

Leave a Reply